These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 24887018)

  • 1. Effect of 1 night of total sleep deprivation on cerebrospinal fluid β-amyloid 42 in healthy middle-aged men: a randomized clinical trial.
    Ooms S; Overeem S; Besse K; Rikkert MO; Verbeek M; Claassen JA
    JAMA Neurol; 2014 Aug; 71(8):971-7. PubMed ID: 24887018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations Between β-Amyloid Kinetics and the β-Amyloid Diurnal Pattern in the Central Nervous System.
    Lucey BP; Mawuenyega KG; Patterson BW; Elbert DL; Ovod V; Kasten T; Morris JC; Bateman RJ
    JAMA Neurol; 2017 Feb; 74(2):207-215. PubMed ID: 27992627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep deprivation and cerebrospinal fluid biomarkers for Alzheimer's disease.
    Olsson M; Ärlig J; Hedner J; Blennow K; Zetterberg H
    Sleep; 2018 May; 41(5):. PubMed ID: 29425372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal Elderly.
    Varga AW; Wohlleber ME; Giménez S; Romero S; Alonso JF; Ducca EL; Kam K; Lewis C; Tanzi EB; Tweardy S; Kishi A; Parekh A; Fischer E; Gumb T; Alcolea D; Fortea J; Lleó A; Blennow K; Zetterberg H; Mosconi L; Glodzik L; Pirraglia E; Burschtin OE; de Leon MJ; Rapoport DM; Lu SE; Ayappa I; Osorio RS
    Sleep; 2016 Nov; 39(11):2041-2048. PubMed ID: 27568802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep Deprivation Induced Plasma Amyloid-β Transport Disturbance in Healthy Young Adults.
    Wei M; Zhao B; Huo K; Deng Y; Shang S; Liu J; Li Y; Ma L; Jiang Y; Dang L; Chen C; Wei S; Zhang J; Yang H; Gao F; Qu Q
    J Alzheimers Dis; 2017; 57(3):899-906. PubMed ID: 28304302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levels.
    Ju YS; Ooms SJ; Sutphen C; Macauley SL; Zangrilli MA; Jerome G; Fagan AM; Mignot E; Zempel JM; Claassen JAHR; Holtzman DM
    Brain; 2017 Aug; 140(8):2104-2111. PubMed ID: 28899014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease.
    Blennow K; Zetterberg H; Rinne JO; Salloway S; Wei J; Black R; Grundman M; Liu E;
    Arch Neurol; 2012 Aug; 69(8):1002-10. PubMed ID: 22473769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers.
    Kester MI; Goos JD; Teunissen CE; Benedictus MR; Bouwman FH; Wattjes MP; Barkhof F; Scheltens P; van der Flier WM
    JAMA Neurol; 2014 Jul; 71(7):855-62. PubMed ID: 24818585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Cerebrospinal Fluid Amyloid-β During Sleep Deprivation in Healthy Middle-Aged Adults Is Not Due to Stress or Circadian Disruption.
    Blattner MS; Panigrahi SK; Toedebusch CD; Hicks TJ; McLeland JS; Banks IR; Schaibley C; Ovod V; Mawuenyega KG; Bateman RJ; Wardlaw SL; Lucey BP
    J Alzheimers Dis; 2020; 75(2):471-482. PubMed ID: 32250301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
    Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
    Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheter.
    Lucey BP; Gonzales C; Das U; Li J; Siemers ER; Slemmon JR; Bateman RJ; Huang Y; Fox GB; Claassen JA; Slats D; Verbeek MM; Tong G; Soares H; Savage MJ; Kennedy M; Forman M; Sjögren M; Margolin R; Chen X; Farlow MR; Dean RA; Waring JF
    Alzheimers Res Ther; 2015; 7(1):53. PubMed ID: 26225140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults.
    Paternicò D; Galluzzi S; Drago V; Bocchio-Chiavetto L; Zanardini R; Pedrini L; Baronio M; Amicucci G; Frisoni GB
    Alzheimers Dement; 2012 Nov; 8(6):520-7. PubMed ID: 22677492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls.
    Sundelöf J; Sundström J; Hansson O; Eriksdotter-Jönhagen M; Giedraitis V; Larsson A; Degerman-Gunnarsson M; Ingelsson M; Minthon L; Blennow K; Kilander L; Basun H; Lannfelt L
    J Alzheimers Dis; 2010; 21(2):471-8. PubMed ID: 20555147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A selected reaction monitoring (SRM)-based method for absolute quantification of Aβ38, Aβ40, and Aβ42 in cerebrospinal fluid of Alzheimer's disease patients and healthy controls.
    Pannee J; Portelius E; Oppermann M; Atkins A; Hornshaw M; Zegers I; Höjrup P; Minthon L; Hansson O; Zetterberg H; Blennow K; Gobom J
    J Alzheimers Dis; 2013; 33(4):1021-32. PubMed ID: 23076076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep quality and preclinical Alzheimer disease.
    Ju YE; McLeland JS; Toedebusch CD; Xiong C; Fagan AM; Duntley SP; Morris JC; Holtzman DM
    JAMA Neurol; 2013 May; 70(5):587-93. PubMed ID: 23479184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings.
    Seppälä TT; Nerg O; Koivisto AM; Rummukainen J; Puli L; Zetterberg H; Pyykkö OT; Helisalmi S; Alafuzoff I; Hiltunen M; Jääskeläinen JE; Rinne J; Soininen H; Leinonen V; Herukka SK
    Neurology; 2012 May; 78(20):1568-75. PubMed ID: 22517093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma beta carotene in Alzheimer's disease. Association with cerebrospinal fluid beta-amyloid 1-40, (Abeta40), beta-amyloid 1-42 (Abeta42) and total Tau.
    Stuerenburg HJ; Ganzer S; Müller-Thomsen T
    Neuro Endocrinol Lett; 2005 Dec; 26(6):696-8. PubMed ID: 16380679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
    Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
    Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low serum potassium in mid life associated with decreased cerebrospinal fluid Abeta42 in late life.
    Mielke MM; Zandi PP; Blennow K; Gustafson D; Sjögren M; Rosengren L; Skoog I
    Alzheimer Dis Assoc Disord; 2006; 20(1):30-6. PubMed ID: 16493233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.